I haven’t posted for a while, and have just been reading. The last while has been a roller coaster ride.
I must say I was happy with the vaccine announcement today, it means no more funds being pumped in from us.
I think Adapt and TAVR will be Admedus’s future.
I know we still have a percentage share in the new company but, every time someone speaks about drug development they say it takes 1 billion dollars to bring a drug to market. Now this new company might fail or they will succeed, if they succeed how much money will have been spent? By the time they have raised $100, $200, $400million even maybe $1 billion, how much would we have been diluted to, percentage wise, assuming we don’t contribute any more funds.
Ann: MOU signed for Admedus Vaccines, page-53
-
- There are more pages in this discussion • 53 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.30 |
Change
0.100(0.76%) |
Mkt cap ! $281.1M | |||
| Open | High | Low | Value | Volume |
| $13.23 | $13.30 | $13.01 | $108.9K | 8.321K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50 | $13.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.35 | 107 | 1 |
View Market Depth
| Last trade - 16.10pm 02/09/2024 (20 minute delay) ? |
| AVR (ASX) Chart |